CalciMedica shareholders approve 7.5 million-share increase to equity incentive plan

• CalciMedica held its annual shareholder meeting on Aug. 19, 2026.
• Shareholders backed an amended 2023 equity incentive plan, lifting the share reserve by 7,500,000 shares.
• Support also covered including shares tied to convertible preferred stock or pre-funded warrants in the plan’s automatic annual increase calculation.
• A reverse stock split was authorized within a 1-for-2 to 1-for-10 range, with a matching cut in authorized common shares; execution left to the board.
• Investors also cleared issuance of Series A warrants for 18,673,429 shares, Series B warrants for 18,673,429 shares, related shares, or pre-funded warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CalciMedica Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-357258), on August 20, 2026, and is solely responsible for the information contained therein.